BRCA1 variations cause greater genomic instability than BRCA2 variations in ovarian cancer8, and ovarian cancer patients with BRCA2 germline mutations show better clinical outcomes than BRCA1-mutated patients9,10. Here, BRCA2 is linked to ovarian carcinoma.